Your browser doesn't support javascript.
loading
Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration.
Raftis, Emma J; Delday, Margaret I; Cowie, Philip; McCluskey, Seánín M; Singh, Mark D; Ettorre, Anna; Mulder, Imke E.
Afiliação
  • Raftis EJ; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
  • Delday MI; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
  • Cowie P; Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, United Kingdom.
  • McCluskey SM; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
  • Singh MD; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
  • Ettorre A; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
  • Mulder IE; 4D Pharma Research Ltd, Life Science Innovation Building, Cornhill Road, Aberdeen, AB25 2ZS, United Kingdom.
Sci Rep ; 8(1): 12024, 2018 08 13.
Article em En | MEDLINE | ID: mdl-30104645

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Terapia Biológica / Microbioma Gastrointestinal / Bifidobacterium breve / Inflamação Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Terapia Biológica / Microbioma Gastrointestinal / Bifidobacterium breve / Inflamação Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article